News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Avoro Capital Advisors LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 0% stake in POINT Biopharma Global Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 0% stake in Relmada Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 4.6% stake in Fennec Pharmaceuticals Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 2.9% stake in Avadel Pharmaceuticals plc |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 2% stake in Arena Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 3.2% stake in PMV Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 5.5% stake in Iovance Biotherapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 8.3% stake in Madrigal Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 14.7% stake in CymaBay Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 6.7% stake in United Therapeutics Corporation |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 7.1% stake in Adverum Biotechnologies, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 8.8% stake in Marinus Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 9.2% stake in Mirati Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 9.7% stake in Xenon Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|